Bayer will offer testing with Veracyte’s RNA sequencing-based Afirma XA to identify underlying genomic drivers of thyroid cancer

December 24, 2020 Leave a comment 4,849 Views

Bayer and Veracyte today announced a new collaboration to advance the Precision Oncology Patient Identification Program in thyroid cancer. Through the program, Bayer will offer testing with...

Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

May 7, 2020 Leave a comment 1,807 Views

Bayer today announced the launch of Test4TRK™ program in collaboration with NeoGenomics, Inc. to offer genomic cancer testing for NTRK gene fusions at no cost for patients with RAI-refractory (RAI-R) differentiated thyroid carcinoma (DTC) and metastatic...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Bayer

Bayer will offer testing with Veracyte’s RNA sequencing-based Afirma XA to identify underlying genomic drivers of thyroid cancer

Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

Voltage-Seq – all-optical voltage imaging-guided postsynaptic single-cell transcriptome profiling

Researchers identify three genes associated with neurodevelopmental disorders

Fragment-Seq – local tissue microenvironments at single-cell resolution

snHH-Seq – pan-cancer single-nucleus total RNA sequencing

Optimised RNA extraction method unlocks tough tissues for aquaculture research

dsRID – in silico identification of dsRNA regions using long-read RNA-seq data

FUN-PROSE – predicting the response of fungal genes